10 Longevity Startups to Watch in 2024
From cellular reprogramming to AI-powered drug discovery, these companies are pushing the boundaries of aging research.
Sarah Chen
Science Editor
The longevity space is experiencing a renaissance, with innovative startups tackling aging from multiple angles. Here are ten companies making waves in 2024.
1. Retro Biosciences
Founded with backing from Sam Altman, Retro is pursuing three parallel approaches: autophagy, plasma-inspired therapeutics, and partial reprogramming.
2. NewLimit
Co-founded by Brian Armstrong, NewLimit focuses on epigenetic reprogramming to restore youthful gene expression patterns.
3. Loyal
Taking a unique approach by first targeting dog longevity, Loyal aims to translate findings to human applications.
4. Fauna Bio
Studying hibernating animals to unlock metabolic secrets that could extend human healthspan.
5. Oisín Biotechnologies
Developing senolytic gene therapies that selectively eliminate senescent cells.
What Sets These Companies Apart
The current generation of longevity startups differs from predecessors in several key ways:
- Scientific rigor: Founded by or closely tied to leading researchers
- Clear endpoints: Focused on measurable biomarkers and clinical outcomes
- Platform approaches: Building technologies applicable across multiple indications
- Patient access: Prioritizing paths to clinical translation
Investment Landscape
Early-stage valuations remain strong, with seed rounds frequently exceeding $10M. Series A rounds in the $30-50M range have become common for companies with compelling preclinical data.
Disclaimer
This content is for informational and educational purposes only and is not medical advice. Always consult a qualified healthcare professional before making changes to your health.
